CAD 0.53
(1.92%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.61 CAD | 45.54% |
2022 | -1.12 CAD | 46.15% |
2021 | -1.83 CAD | 15.61% |
2020 | -2.17 CAD | 23.95% |
2019 | -2.85 CAD | 32.0% |
2018 | -4.14 CAD | -16.67% |
2017 | -3.73 CAD | 91.43% |
2016 | -1.40 CAD | -478.38% |
2015 | 0.37 CAD | 104.66% |
2014 | -7.94 CAD | -85.51% |
2013 | -4.28 CAD | -3790.91% |
2012 | -0.11 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.32 CAD | 47.54% |
2024 Q2 | -0.40 CAD | -25.0% |
2024 Q3 | -0.28 CAD | 30.0% |
2023 Q4 | -0.61 CAD | -654.55% |
2023 Q1 | -0.01 CAD | 98.34% |
2023 FY | - CAD | 38.6% |
2023 Q2 | -0.05 CAD | -291.27% |
2023 Q3 | 0.11 CAD | 323.12% |
2022 FY | - CAD | 46.15% |
2022 Q3 | 0.02 CAD | 240.63% |
2022 Q4 | -0.03 CAD | -244.44% |
2022 Q1 | -0.00 CAD | 93.25% |
2022 Q2 | -0.02 CAD | -515.38% |
2021 Q3 | -0.01 CAD | -50.0% |
2021 FY | - CAD | 15.61% |
2021 Q4 | -0.04 CAD | -185.19% |
2021 Q2 | -0.01 CAD | -250.0% |
2021 Q1 | 0.01 CAD | 108.03% |
2020 FY | - CAD | 23.95% |
2020 Q1 | -0.01 CAD | 38.74% |
2020 Q2 | -0.01 CAD | 35.9% |
2020 Q3 | -0.00 CAD | 65.33% |
2020 Q4 | -0.07 CAD | -2773.08% |
2019 Q3 | -0.02 CAD | 16.89% |
2019 Q1 | -0.03 CAD | 18.51% |
2019 Q2 | -0.02 CAD | 30.91% |
2019 Q4 | -0.02 CAD | -4.95% |
2019 FY | - CAD | 32.0% |
2018 Q2 | -0.33 CAD | -4300.0% |
2018 Q3 | -0.03 CAD | 91.12% |
2018 FY | - CAD | -16.67% |
2018 Q4 | -0.04 CAD | -32.76% |
2018 Q1 | -0.01 CAD | 0.0% |
2017 Q1 | -0.02 CAD | 0.0% |
2017 Q4 | - CAD | 100.0% |
2017 Q3 | -0.03 CAD | -264.44% |
2017 Q2 | -0.01 CAD | 47.98% |
2017 FY | - CAD | 91.43% |
2016 FY | - CAD | -478.38% |
2016 Q2 | -0.07 CAD | 5.76% |
2016 Q1 | -0.07 CAD | 25.4% |
2016 Q4 | - CAD | 100.0% |
2016 Q3 | -0.06 CAD | 16.93% |
2015 FY | - CAD | 104.66% |
2015 Q3 | -0.28 CAD | -134.15% |
2015 Q1 | -0.07 CAD | 0.0% |
2015 Q2 | 0.82 CAD | 1274.79% |
2015 Q4 | -0.10 CAD | 64.29% |
2014 Q3 | -0.49 CAD | -122.73% |
2014 Q1 | -0.66 CAD | 0.0% |
2014 FY | - CAD | -85.51% |
2014 Q4 | - CAD | 100.0% |
2014 Q2 | -0.22 CAD | 66.67% |
2013 Q1 | -0.01 CAD | 0.0% |
2013 FY | - CAD | -3790.91% |
2013 Q2 | - CAD | 100.0% |
2013 Q3 | -0.30 CAD | 0.0% |
2013 Q4 | - CAD | 100.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | 61.875% |
Avicanna Inc. | -0.09 CAD | -555.209% |
Cardiol Therapeutics Inc. | -0.44 CAD | -38.636% |
Crescita Therapeutics Inc. | -0.10 CAD | -522.449% |
Knight Therapeutics Inc. | -0.16 CAD | -281.25% |
MediPharm Labs Corp. | -0.04 CAD | -1594.444% |
OrganiGram Holdings Inc. | -2.82 CAD | 78.369% |
Canopy Growth Corporation | -8.79 CAD | 93.06% |
Willow Biosciences Inc. | -0.10 CAD | -510.0% |
Auxly Cannabis Group Inc. | -0.04 CAD | -1258.575% |